NIH Issues Ten-Year Strategic Plan For Diabetes Research
This article was originally published in The Gray Sheet
The National Institutes of Health has mapped out a new strategic plan to guide diabetes research during the next decade. Among the priorities: developing artificial pancreas technologies and identifying genetic factors that influence susceptibility to diabetes and its complications.
You may also be interested in...
The U.S. health care reform law and its insurance coverage expansion will help improve the lives of patients with diabetes, but an ongoing provider shortage threatens to counter any positive effect, analysts warn.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.